Virpax Pharmaceuticals and Kindeva Drug Delivery have entered a partnership to work together to advance the clinical program of the Virpax-developed Diclofenac topical spray film (Epoladerm) in the U.S. The product is being studied for the treatment of pain associated with osteoarthritis of the knee. Using Kindeva’s state-of-the-art facilities located in Woodbury, MN, they will bring this product from an existing lab-scale formulation to a phase II and III clinical supply. “We are excited to ...